Search research articles
Contact Us
Filters
Showing results (71-80 of 136) with videos related to
Page
of 14
Sort By:
The Oncologist
|
April 20, 2016
Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer
Neeraj Agarwal, Jean-Pascal Machiels, Cristina Suárez, et al.
Clinical Breast Cancer
|
December 18, 2013
Feasibility of 4 cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: a Wisconsin Oncology Network study
Mark E Burkard, Kari B Wisinski, Uchenna O Njiaju, et al.
Oncoimmunology
|
February 7, 2019
Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model
Jose M Ayuso, Regan Truttschel, Max M Gong, et al.
The American Journal of Pathology
|
February 13, 2018
The Presence of Cyclooxygenase 2, Tumor-Associated Macrophages, and Collagen Alignment as Prognostic Markers for Invasive Breast Carcinoma Patients
Karla Esbona, Yanyao Yi, Sandeep Saha, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
March 13, 2024
The prostaglandin E<sub>2</sub> EP3 receptor has disparate effects on islet insulin secretion and content in β-cells in a high-fat diet-induced mouse model of obesity
Joshua C Neuman, Austin Reuter, Kathryn A Carbajal, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 30, 2024
Measurable Residual Disease Testing Following Nonintensive Chemoimmunotherapy is Predictive of Need for Maintenance Therapy in Previously Untreated Mantle Cell Lymphoma: A Wisconsin Oncology Network Study
Julie E Chang, Danielle McQuinn, Meredith Hyun, et al.
Molecular Cancer Therapeutics
|
November 21, 2015
Identification of Selective Lead Compounds for Treatment of High-Ploidy Breast Cancer
Alka Choudhary, Brittany Zachek, Robert F Lera, et al.
Cancer
|
November 24, 2020
Results from a prospective longitudinal survey of employment and work outcomes in newly diagnosed cancer patients during and after curative-intent chemotherapy: A Wisconsin Oncology Network study
Amye J Tevaarwerk, Kris Kwekkeboom, Kevin A Buhr, et al.
Cancer
|
June 18, 2021
Reply to The effects of curative-intent cancer therapy on employment, work ability, and work limitations
Amye J Tevaarwerk, Kris Kwekkeboom, Kevin A Buhr, et al.
Oncogene
|
March 1, 2026
Obesity and breast density enhance immune exclusion in the primary tumor microenvironment and promote breast cancer metastasis
Abbey E Williams, Erica J Hoffmann, David R Inman, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 136) with videos related to
Sort By:
Page
of 14
The Oncologist
|
April 20, 2016
Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer
Neeraj Agarwal, Jean-Pascal Machiels, Cristina Suárez, et al.
Clinical Breast Cancer
|
December 18, 2013
Feasibility of 4 cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: a Wisconsin Oncology Network study
Mark E Burkard, Kari B Wisinski, Uchenna O Njiaju, et al.
Oncoimmunology
|
February 7, 2019
Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model
Jose M Ayuso, Regan Truttschel, Max M Gong, et al.
The American Journal of Pathology
|
February 13, 2018
The Presence of Cyclooxygenase 2, Tumor-Associated Macrophages, and Collagen Alignment as Prognostic Markers for Invasive Breast Carcinoma Patients
Karla Esbona, Yanyao Yi, Sandeep Saha, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
March 13, 2024
The prostaglandin E<sub>2</sub> EP3 receptor has disparate effects on islet insulin secretion and content in β-cells in a high-fat diet-induced mouse model of obesity
Joshua C Neuman, Austin Reuter, Kathryn A Carbajal, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 30, 2024
Measurable Residual Disease Testing Following Nonintensive Chemoimmunotherapy is Predictive of Need for Maintenance Therapy in Previously Untreated Mantle Cell Lymphoma: A Wisconsin Oncology Network Study
Julie E Chang, Danielle McQuinn, Meredith Hyun, et al.
Molecular Cancer Therapeutics
|
November 21, 2015
Identification of Selective Lead Compounds for Treatment of High-Ploidy Breast Cancer
Alka Choudhary, Brittany Zachek, Robert F Lera, et al.
Cancer
|
November 24, 2020
Results from a prospective longitudinal survey of employment and work outcomes in newly diagnosed cancer patients during and after curative-intent chemotherapy: A Wisconsin Oncology Network study
Amye J Tevaarwerk, Kris Kwekkeboom, Kevin A Buhr, et al.
Cancer
|
June 18, 2021
Reply to The effects of curative-intent cancer therapy on employment, work ability, and work limitations
Amye J Tevaarwerk, Kris Kwekkeboom, Kevin A Buhr, et al.
Oncogene
|
March 1, 2026
Obesity and breast density enhance immune exclusion in the primary tumor microenvironment and promote breast cancer metastasis
Abbey E Williams, Erica J Hoffmann, David R Inman, et al.
Page
of 14